J. Dedrick Jordan

ORCID: 0000-0002-0706-9583
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Acute Ischemic Stroke Management
  • Intracranial Aneurysms: Treatment and Complications
  • Intracerebral and Subarachnoid Hemorrhage Research
  • Protein Kinase Regulation and GTPase Signaling
  • Lipoproteins and Cardiovascular Health
  • Metabolism, Diabetes, and Cancer
  • Cardiac Arrest and Resuscitation
  • Advanced Sensor Technologies Research
  • Traumatic Brain Injury Research
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Receptor Mechanisms and Signaling
  • Analytical Chemistry and Sensors
  • Pancreatic function and diabetes
  • Intensive Care Unit Cognitive Disorders
  • S100 Proteins and Annexins
  • Neuroscience and Neuropharmacology Research
  • Health Systems, Economic Evaluations, Quality of Life
  • Nuclear and radioactivity studies
  • Acute Kidney Injury Research
  • Cerebrovascular and Carotid Artery Diseases
  • Water Quality and Resources Studies
  • Advanced Optical Sensing Technologies
  • Fibroblast Growth Factor Research
  • Ion channel regulation and function

Louisiana State University
2025

PSG INSTITUTE OF TECHNOLOGY AND APPLIED RESEARCH
2025

Louisiana State University Health Sciences Center Shreveport
2023-2024

Duke University
2014-2024

University of North Carolina at Chapel Hill
2012-2020

University of North Carolina Health Care
2017

Boston Medical Center
2017

Icahn School of Medicine at Mount Sinai
1998-2012

Medizinische Hochschule Hannover
2010

Johns Hopkins University
2006-2010

Adrian F. Hernandez Jennifer B. Green Salim Janmohamed Ralph B. D’Agostino Christopher B. Granger and 95 more Nigel C. Jones Lawrence A. Leiter Anne E Rosenberg Kristina N. Sigmon Matthew C. Somerville Karl M. Thorpe John J.V. McMurray Stefano Del Prato Stefano Del Prato John J.V. McMurray Ralph B. D’Agostino Christopher B. Granger Adrian F. Hernandez Salim Janmohamed Lawrence A. Leiter Robert M. Califf Rury R. Holman David L. DeMets Matthew C. Riddle Shaun G. Goodman Darren K. McGuire Karen Alexander Adam D. DeVore Chiara Melloni Chetan B. Patel David C. M. Kong Gerald S. Bloomfield Matthew T. Roe Pierluigi Tricoci Robert W. Harrison Renato D. Lópes Robin Mathews Rajendra Mehta W. Schuyler Jones Sreekanth Vemulapalli Thomas J. Povsic Zubin J. Eapen Keith Dombrowski Brad J. Kolls J. Dedrick Jordan Andrew P. Ambrosy Stephen J. Greene Aditya Mandawat Jay Shavadia Lauren B. Cooper Abhinav Sharma Patrícia O. Guimarães Daniel J. Friedman Matthew E. Wilson Patricia Endsley Tracy Gentry Jeannie Collier Kathleen Perez K.E. James Jennifer Roush C. ARDEN III POPE Christina Howell Megan Johnson M. Bailey Joanna Cole Teresa Akers Beth Vandyne Betsy Thomas Jenny Rich Susan Bartone Gail Beaulieu Kim Brown Tuan Chau Tamra Christian Rebecca Coker Deb Greene Trevorlyn Haddock Wendy Jenkins Ghazala Haque Marsha L. Marquess Jean Pesarchick Renee Rethaford Allegra Stone Firas Al- Kawas Michelle A. Anderson Robert Enns Isaac Sinay Chantal Mathieu Victor Yordanov Irene Hramiak Martin Haluzı́k Søren Galatius Bruno Guerci Michael A. Nauck Ilias Migdalis Kathryn Choon Beng Tan Győző Kocsis Andrea Giaccari Moon Kyu Lee Ernesto Muñoz

10.1016/s0140-6736(18)32261-x article EN The Lancet 2018-10-01
Renato D. Lópes Celestia S. Higano Susan F. Slovin Adam J. Nelson Robert Bigelow and 95 more Per Settergren Sørensen Chiara Melloni Shaun G. Goodman Christopher P. Evans Jan Nilsson Deepak L. Bhatt Noel W. Clarke Tine Kold Olesen Belinda T. Doyle-Olsen Henriette Kristensen Lauren Arney Matthew T. Roe John H. Alexander Mirjam Mol-Arts Samreen Mansor-Lefebvre Konstantin Zubovskiy Allan Blemings Klaus A. Dugi Gerald S. Bloomfield Chris Kontos Adam D. DeVore J. Dedrick Jordan Brad J. Kolls J. B. Matthews Rajendra H. Mehta Thomas J. Povsic Michael Morse Kenneth W. Mahaffey Susan Halabi Darryl P. Leong Laurence Klotz Neil Fleshner G. Kenneth Jansz Jonathan Giddens R. Blair Egerdie Joseph L. Chin Joseph Zadra Richard Casey Jean Simard Tamim Niazi André‐Guy Martin Marek Babjuk Jaroslav Hájek Jiří Klečka Jiří Kubeš Jan Schraml Jitka Jakesova J Vaňásek Bohuslav Melichar Heikki Seikkula M. Abdiche Marc Colombel P. Debourdeau G. Robert Arnauld Villers Guillaume Ploussard Benjamin Pradère F. Bruyère Jean‐Luc Descotes I. Ouzaïd Alexander Winter Herbert Hanitzsch H. Sperling Ralf Eckert Peter Hammerer E. Stagge F. Seseke Silvio Szymula Aristotelis Bamias A. Thanos Konstantinos Hatzimouratidis Charalambos Mamoulakis Haralabos P. Kalofonos Elżbieta Oszukowska Katarzyna Madziarska Jacek Fijuth Mateusz Obarzanowski B. Yа. Alekseev Vagif Atduev Pushkar' DIu Evgeniy Veliev A. V. Zyryаnov С Б Петров Evgeny Kopyltsov Vadim Kozlov Ladislav Macko J. Dúbravický Richard Polak Obaidullah Mir Marek Vargovcak I. Minčík J. Kliment Frederico Gonçalves J Mikuláš Roman Sokol

The relative cardiovascular safety of gonadotropin-releasing hormone (GnRH) antagonists compared with GnRH agonists in men prostate cancer and known atherosclerotic disease remains controversial.In this international, multicenter, prospective, randomized, open-label trial, concomitant were randomly assigned 1:1 to receive the antagonist degarelix or agonist leuprolide for 12 months. primary outcome was time first adjudicated major adverse event (composite death, myocardial infarction,...

10.1161/circulationaha.121.056810 article EN Circulation 2021-08-30

The PCSK9 antibody alirocumab (75 mg every 2 weeks; Q2W) as monotherapy reduced low-density lipoprotein-cholesterol (LDL-C) levels by 47%. Because the option of a monthly dosing regimen is convenient, ODYSSEY CHOICE II evaluated 150 Q4W in patients with inadequately controlled hypercholesterolemia and not on statin (majority statin-associated muscle symptoms), receiving treatment fenofibrate, ezetimibe, or diet alone.Patients were randomly assigned to placebo, 75 Q2W (calibrator arm), dose...

10.1161/jaha.116.003421 article EN cc-by-nc-nd Journal of the American Heart Association 2016-09-01

We used the yeast two-hybrid system to identify proteins that interact directly with Gα<sub>o</sub>. Mutant-activated Gα<sub>o</sub> was as bait screen a cDNA library from chick dorsal root ganglion neurons. found interacted several including Gz-GTPase-activating protein (Gz-GAP), new RGS (RGS-17), novel of unknown function (IP6), and Rap1GAP. This study focuses on Rap1GAP, which selectively interacts Gα<sub>o</sub>and Gα<sub>i</sub> but not Gα<sub>s</sub> or Gα<sub>q</sub>. Rap1GAP more...

10.1074/jbc.274.31.21507 article EN cc-by Journal of Biological Chemistry 1999-07-01

The Gαo/i-coupled CB1 cannabionoid receptor induces neurite outgrowth in Neuro-2A cells. mechanisms of signaling through Gαo/i to induce were studied. expression reduces the stability its direct interactor protein, Rap1GAPII, by targeting it for ubiquitination and proteasomal degradation. This results activation Rap1. Gαo/i-induced endogenous Rap1 cells is blocked inhibitor lactacystin. stimulates that dominant negative Expression Rap1GAPII also blocks treatment with inhibitors potentiates...

10.1074/jbc.m411521200 article EN cc-by Journal of Biological Chemistry 2005-01-19

Background and Purpose— EG-1962 is a sustained release formulation of nimodipine administered via external ventricular drain in patients with aneurysmal subarachnoid hemorrhage. A randomized, open-label, phase 1/2a, dose-escalation study provided impetus for this to evaluate efficacy safety single intraventricular 600 mg dose hemorrhage, compared standard care oral nimodipine. Methods— Subjects were World Federation Neurological Surgeons grades 2–4, modified Fisher 2–4 had an inserted as...

10.1161/strokeaha.119.027396 article EN Stroke 2020-03-18

Cellular senescence is an irreversible and multifaceted process inducing tissue dysfunction organismal aging, thus the clearance of senescent cells can prevent or delay onset aging-related pathologies. Herein, we developed augmented photothermal therapy strategy integrated with antibody against β2-microglobulin (aB2MG) immune adjuvant imiquimod (R837) to effectively accelerate cell apoptosis under a near-infrared light. With this strategy, designed CroR@aB2MG enables targeting application...

10.14336/ad.2023.0628 article EN cc-by Aging and Disease 2023-08-02

ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTDynamics of Acrylodan-Labeled Bovine and Human Serum Albumin Entrapped in a Sol-Gel-Derived BiogelJeffrey D. Jordan, Richard A. Dunbar, Frank V. BrightCite this: Anal. Chem. 1995, 67, 14, 2436–2443Publication Date (Print):July 15, 1995Publication History Published online1 May 2002Published inissue 15 July 1995https://doi.org/10.1021/ac00110a019RIGHTS & PERMISSIONSArticle Views204Altmetric-Citations95LEARN ABOUT THESE METRICSArticle Views are the...

10.1021/ac00110a019 article EN Analytical Chemistry 1995-07-15

Background and Purpose- Predictors of stroke transient ischemic attack (TIA) in patients with peripheral artery disease (PAD) are poorly understood. The primary aims this analysis were to (1) determine the incidence ischemic/hemorrhagic TIA symptomatic PAD, (2) identify predictors (3) compare rate ticagrelor- clopidogrel-treated patients. Methods- EUCLID (Examining Use Ticagrelor Peripheral Artery Disease) randomized 13 885 PAD receive monotherapy ticagrelor or clopidogrel for prevention...

10.1161/strokeaha.118.023534 article EN Stroke 2019-05-16

Abstract Background The purpose of this study was to examine the impact ARC on levetiracetam concentrations during first week following acute TBI. hypothesis are significantly lower in TBI patients with augmented renal clearance (ARC) compared those normal clearance. Methods This is a prospective cohort pharmacokinetic adults moderate severe treated after injury. Serial blood collections were performed daily for analysis levetiracetam, cystatin C, and 12-hr creatinine (CrCl) determinations....

10.1186/s12883-023-03515-w article EN cc-by BMC Neurology 2024-01-02

To evaluate enhanced renal clearance over time in patients with aneurysmal subarachnoid hemorrhage or intracerebral via measured creatinine and to compare calculated by the Cockcroft-Gault equation estimated glomerular filtration rate Modification of Diet Renal Diseases equation.Prospective, observational study.Neurosciences ICU a tertiary care academic medical center.Study participants had an admission diagnosis hemorrhage, expected neurosciences length stay greater than 48 hours, no...

10.1097/ccm.0000000000003716 article EN Critical Care Medicine 2019-03-17

Rationale: Adverse experiences in early life including abuse, trauma and neglect, have been linked to poor physical mental health outcomes. Emerging evidence implies that those who experienced adversity (ELA) are more likely develop cognitive dysfunction depressive-like symptoms adulthood. The molecular mechanisms responsible for the negative consequences of ELA, however, remain unclear. In absence effective management options, anticipatory guidance is mainstay ELA prevention. Furthermore,...

10.7150/thno.78777 article EN cc-by Theranostics 2023-01-01

Norepinephrine inhibits omega-conotoxin GVIA-sensitive presynaptic Ca2+ channels in chick dorsal root ganglion neurons through two pathways, one mediated by Go and the other Gi. These pathways desensitize at different rates. We have found that recombinant Galpha interacting protein (GAIP) regulators of G signaling (RGS)4 selectively accelerate rate desensitization Go- Gi-mediated respectively. Blockade endogenous RGS proteins using antibodies raised against RGS4 slows these a selective...

10.1074/jbc.274.20.14490 article EN cc-by Journal of Biological Chemistry 1999-05-01

Stroke patients requiring decompressive craniectomy are at high risk of prolonged mechanical ventilation and ventilator-associated pneumonia (VAP). Tracheostomy placement may reduce the duration ventilation. Predicting which will require tracheostomy optimal timing remains a clinical challenge. In this study, authors compare key outcomes after early versus late develop useful pre-operative decision-making tool to predict post-operative dependence. We performed retrospective analysis...

10.1186/s40560-017-0269-1 article EN cc-by Journal of Intensive Care 2018-01-04
Coming Soon ...